Sex hormones, testosterone and estrogen alter cardiovascular risk factors raising a man's risk of heart disease, demonstrates a new study.
The study conducted by the Endocrine Society suggested that men have higher testosterone and lower estrogen levels than premenopausal women and, therefore, doctors have suspected that testosterone may promote cardiovascular disease or that estrogen may protect against it, or both.
The study, conducted in 400 healthy men ages 20 to 50, found that higher levels of testosterone led to lower levels of HDL cholesterol, or "good" cholesterol, but estrogen appeared to have no effect on HDL cholesterol. In contrast, the investigators reported that low levels of estrogen led to higher fasting blood glucose (sugar) levels, worsening insulin resistance and more fat in muscle, markers for developing diabetes, which is itself a risk factor for heart disease.
The other group, made up of 202 men, received the same treatment as in group 1 but also received anastrozole (Arimidex, AstraZeneca) to block conversion of testosterone to estrogen. Men naturally convert some testosterone to estrogen.
Study participants had their weight measured and had fasting blood tests for markers of heart disease and diabetes. At the start and end of the study, they had a thigh scan with quantitative computed tomography (CT) to measure muscle fat.
The researchers found that neither testosterone nor estrogen regulated changes in LDL, or "bad" cholesterol, blood pressure and body weight.
Elaine Yu, MD, MSc, the study's lead investigator and an assistant professor at Harvard Medical School, Boston, asserted that these observations may help explain why men have a higher risk of cardiovascular disease.